NCT07409688 Pain Relief Following Laparoscopic Cholecystectomy While Comparing Intra Abdominal Versus Sub Cutaneous Local Anesthetic Administration
| NCT ID | NCT07409688 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Rawalpindi Medical College |
| Condition | Laparoscopic Cholecystectomy Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-01-17 |
| Primary Completion | 2026-06-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 100 participants in total. It began in 2026-01-17 with a primary completion date of 2026-06-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Laparoscopic cholecystectomy involves removal of gallbladder through small incision ports resulting in faster recovery. Small incisions are less painful and hence local anesthesis administered can be effective for pain management. This local anesthetic can be administered either within abdominal cavity or at sit of small incisions.
Eligibility Criteria
Inclusion Criteria: * ASA I and II Exclusion Criteria: * Allergic to local anesthetic Open cholecystectomy History of chronic pain History of abdominal surgery
Contact & Investigator
Waqas Anjum
STUDY CHAIR
Rawalpindi Medical College
Frequently Asked Questions
Who can join the NCT07409688 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 60 Years, studying Laparoscopic Cholecystectomy Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07409688 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07409688 currently recruiting?
Yes, NCT07409688 is actively recruiting participants. Contact the research team at drnimrahiqbal@gmail.com for enrollment information.
Where is the NCT07409688 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan.
Who is sponsoring the NCT07409688 clinical trial?
NCT07409688 is sponsored by Rawalpindi Medical College. The principal investigator is Waqas Anjum at Rawalpindi Medical College. The trial plans to enroll 100 participants.